المؤلفون: Reinmuth, N., Cho, B.C., Hussein, M., Chen, C.C-K., He, J., Doake, R., Runswick, S., Johnson, M.L.

المساهمون: AstraZeneca

المصدر: Annals of Oncology ; volume 32, page S1449 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2021.10.177Test
https://api.elsevier.com/content/article/PII:S092375342104713X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342104713X?httpAccept=text/plainTest

المؤلفون: Robson, M. E., Tung, N., Conte, P., Im, S. -A., Senkus, E., Xu, B., Masuda, N., Delaloge, S., Li, W., Armstrong, A., Wu, W., Goessl, C., Runswick, S., Domchek, S. M.

المساهمون: 임석아, Im, S. -A.

مصطلحات موضوعية: breast cancer, germline BRCA mutation, overall survival, PARP inhibitor, olaparib, tolerability

العلاقة: Annals of Oncology, Vol.30 No.4, pp.558-566; 93710; https://hdl.handle.net/10371/177331Test; 000468283900011; 2-s2.0-85066163641

الإتاحة: https://doi.org/10.1093/annonc/mdz012Test
https://hdl.handle.net/10371/177331Test

المؤلفون: Robson, M.E., Tung, N., Conte, P., Im, S.-A., Senkus, E., Xu, B., Masuda, N., Delaloge, S., Li, W., Armstrong, A., Wu, W., Goessl, C., Runswick, S., Domchek, S.M.

المساهمون: AstraZeneca, AstraZeneca and Merck & Co., Inc., NIH/NCI Cancer Center, Breast Cancer Research Foundation, Mudskipper Business Ltd

المصدر: Annals of Oncology ; volume 30, issue 4, page 558-566 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdz012Test
https://api.elsevier.com/content/article/PII:S0923753419311111?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419311111?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/30/4/558/28641064/mdz012.pdfTest

المؤلفون: Lheureux, S, Lai, Z, Dougherty, BA, Runswick, S, Hodgson, DR, Timms, KM, Lanchbury, JS, Kaye, S, Gourley, C, Bowtell, D, Kohn, EC, Scott, C, Matulonis, U, Panzarella, T, Karakasis, K, Burnier, JV, Gilks, CB, O'Connor, MJ, Robertson, JD, Ledermann, J, Barrett, JC, Ho, TW, Oza, AM

المصدر: Clinical Cancer Research , 23 (15) pp. 4086-4094. (2017)

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/1543479/1/Lheureux_Long-Term_Responders_Olaparib_Maintenance.pdfTest; https://discovery.ucl.ac.uk/id/eprint/1543479Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/1543479/1/Lheureux_Long-Term_Responders_Olaparib_Maintenance.pdfTest
https://discovery.ucl.ac.uk/id/eprint/1543479Test/

المؤلفون: Delaloge, S., Conte, P.F., Im, S-A., Senkus-Konefka, E., Xu, B., Domchek, S.M., Masuda, N., Li, W., Tung, N., Armstrong, A., Wu, W., Goessl, C., Runswick, S., Robson, M.

المصدر: Annals of Oncology ; volume 28, page v77 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdx365.006Test
https://api.elsevier.com/content/article/PII:S0923753420376675?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420376675?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.006/19938725/mdx365.006.pdfTest

المؤلفون: Schlicker, A. (author), Beran, G. (author), Chresta, C.M. (author), McWalter, G. (author), Pritchard, A. (author), Weston, S. (author), Runswick, S. (author), Davenport, S. (author), Heathcote, K. (author), Alferez Castro, D. (author), Orphanides, G. (author), French, T. (author), Wessels, L.F.A. (author)

مصطلحات موضوعية: colorectal cancer, tumor subtyping, cell lines, targeted therapy

العلاقة: BMC Medical Genomics, 5, 2012--1755-8794; http://www.biomedcentral.com/1755-8794/5/66Test; https://doi.org/10.1186/1755-8794-5-66Test; http://resolver.tudelft.nl/uuid:538a9813-5214-4fb8-91a5-ec072868eb48Test

الإتاحة: https://doi.org/10.1186/1755-8794-5-66Test
http://resolver.tudelft.nl/uuid:538a9813-5214-4fb8-91a5-ec072868eb48Test

المؤلفون: Tasevska, N, Runswick, S A, Welch, A A, McTaggart, A, Bingham, S A

المصدر: European Journal of Clinical Nutrition ; volume 63, issue 5, page 653-659 ; ISSN 0954-3007 1476-5640

مصطلحات موضوعية: Nutrition and Dietetics, Medicine (miscellaneous)

الإتاحة: https://doi.org/10.1038/ejcn.2008.21Test
https://www.nature.com/articles/ejcn200821.pdfTest
https://www.nature.com/articles/ejcn200821Test

المؤلفون: Neuhouser, M. L., Tinker, L., Shaw, P. A., Schoeller, D., Bingham, S. A., Horn, L. V., Beresford, S. A. A., Caan, B., Thomson, C., Satterfield, S., Kuller, L., Heiss, G., Smit, E., Sarto, G., Ockene, J., Stefanick, M. L., Assaf, A., Runswick, S., Prentice, R. L.

المصدر: American Journal of Epidemiology ; volume 167, issue 10, page 1247-1259 ; ISSN 0002-9262 1476-6256

الإتاحة: https://doi.org/10.1093/aje/kwn026Test
http://academic.oup.com/aje/article-pdf/167/10/1247/629329/kwn026.pdfTest

المؤلفون: Tasevska, N, Runswick, S A, McTaggart, A, Bingham, S A

المصدر: European Journal of Clinical Nutrition ; volume 62, issue 9, page 1139-1147 ; ISSN 0954-3007 1476-5640

مصطلحات موضوعية: Nutrition and Dietetics, Medicine (miscellaneous)

الإتاحة: https://doi.org/10.1038/sj.ejcn.1602829Test
https://www.nature.com/articles/1602829.pdfTest
https://www.nature.com/articles/1602829Test

المؤلفون: Robson, M, Im, S, Senkus, E, Xu, B, Domchek, S, Masuda, N, Delaloge, S, Li, W, Tung, N, Armstrong, Anne C, Wu, W, Goessl, C, Runswick, S, Conte, P

المساهمون: Memorial Sloan Kettering Cancer Center, New York, NY

العلاقة: https://dx.doi.org/10.1158/1538-7445.AM2018-CT038Test; Robson ME, Im S-A, Senkus E, Xu B, Domchek S, Masuda N, et al. OlympiAD final overall survival: olaparib versus chemotherapy treatment of physician's choice (TPC) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm). Cancer Res. 2018;78(13).; http://hdl.handle.net/10541/622033Test; Cancer Research

الإتاحة: https://doi.org/10.1158/1538-7445.AM2018-CT038Test
http://hdl.handle.net/10541/622033Test